Bepantiseptic First Aid Cream

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Phenol; Chlorhexidine digluconate

から入手可能:

Bayer Limited

ATCコード:

D08AC; D08AC52

INN（国際名）:

Phenol; Chlorhexidine digluconate

投薬量:

1.2 %w/w/0.25 percent weight/weight

医薬品形態:

Cream

処方タイプ:

Product not subject to medical prescription

治療領域:

Biguanides and amidines; chlorhexidine, combinations

認証ステータス:

Marketed

承認日:

1987-01-02

製品の特徴

Health Products Regulatory Authority
05 December 2022
CRN00D655
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Bepantiseptic First Aid Cream
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Phenol
1.20
% w/w
Chlorhexidine Digluconate Solution
to give Chlorhexidine Digluconate
0.25
% w/w
Also contains cetostearyl alcohol 10% w/w.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cream.
A pink, viscous, homogeneous cream.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the treatment of minor skin irritations.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Apply as necessary after cleansing for up to 3 days.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section
6.1.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If symptoms persist or the condition worsens, consult your doctor.
Rare but serious allergic reactions including anaphylaxis have been
reported with use of chlorhexidine containing antiseptic
products. If symptoms of a serious allergic reaction appear (e.g.
wheezing or difficulty breathing, swelling of the face, hives that
can quickly progress to more serious symptoms, severe rash, or shock),
use must be discontinued immediately and doctor
should be consulted.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Chlorhexidine is incompatible with anionic agents.
4.6 FERTILITY, PREGNANCY AND LACTATION
Although use of this product is not contraindicated during pregnancy
and lactation, as with all medicines during pregnancy,
caution should be exercised.
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Health Products Regulatory Authority
05 December 2022
CRN00D655
Page 2 of 4
None known.
4.8 UNDESIRABLE EFFECTS
Spontaneous reports of hypersensitivity reactions (hypersensitivity,
anaphylactic reaction, anaphylactic shock) have been made;
frequency of these reactions cannot be estimated from the available
data.
Rarely irritancy, rashes and other skin conditions may occur.
REPORTING OF SUSPE